Vanguard Group Inc. Decreases Stake in Envista Holdings Corporation $NVST

Vanguard Group Inc. cut its holdings in Envista Holdings Corporation (NYSE:NVST) by 1.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,096,482 shares of the company’s stock after selling 287,226 shares during the quarter. Vanguard Group Inc. owned 0.10% of Envista worth $349,455,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. Chicago Partners Investment Group LLC boosted its stake in shares of Envista by 9.2% in the fourth quarter. Chicago Partners Investment Group LLC now owns 22,450 shares of the company’s stock valued at $535,000 after buying an additional 1,898 shares in the last quarter. Optas LLC boosted its stake in shares of Envista by 81.4% in the fourth quarter. Optas LLC now owns 22,054 shares of the company’s stock valued at $479,000 after buying an additional 9,894 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Envista by 3.9% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 49,240 shares of the company’s stock valued at $1,069,000 after buying an additional 1,854 shares in the last quarter. Krilogy Financial LLC purchased a new stake in shares of Envista in the fourth quarter valued at approximately $244,000. Finally, Lecap Asset Management Ltd. purchased a new stake in Envista during the fourth quarter worth $386,000.

Envista Stock Down 9.8%

Shares of NYSE:NVST opened at $24.41 on Friday. The company has a quick ratio of 2.04, a current ratio of 2.38 and a debt-to-equity ratio of 0.47. Envista Holdings Corporation has a 52-week low of $16.41 and a 52-week high of $30.42. The stock’s fifty day simple moving average is $26.53 and its 200-day simple moving average is $24.06. The company has a market capitalization of $3.98 billion, a P/E ratio of 59.54, a P/E/G ratio of 1.85 and a beta of 0.92.

Envista (NYSE:NVST) last released its earnings results on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05. The firm had revenue of $705.50 million during the quarter, compared to analyst estimates of $680.04 million. Envista had a return on equity of 7.09% and a net margin of 2.41%.The business’s quarterly revenue was up 14.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.24 earnings per share. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, equities research analysts forecast that Envista Holdings Corporation will post 1.4 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Envista news, SVP Mischa Reis sold 9,675 shares of the company’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total transaction of $290,250.00. Following the completion of the sale, the senior vice president directly owned 32,382 shares in the company, valued at $971,460. This represents a 23.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.99% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

NVST has been the topic of a number of research analyst reports. Citigroup initiated coverage on Envista in a research report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 target price on the stock. Wall Street Zen upgraded Envista from a “buy” rating to a “strong-buy” rating in a research report on Monday, January 26th. Piper Sandler reiterated a “neutral” rating and set a $25.00 target price (up from $21.00) on shares of Envista in a research report on Friday, February 6th. Robert W. Baird boosted their target price on Envista from $30.00 to $31.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, Leerink Partners set a $35.00 target price on Envista and gave the stock an “outperform” rating in a research report on Friday, February 6th. Six equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $28.83.

Trending Headlines about Envista

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Q1 results beat consensus: Envista reported $0.36 EPS vs. $0.31 consensus and revenue of $705.5M (above estimates), showing 14% top-line growth year-over-year — a core reason for bullish analyst commentary. PR Newswire: Q1 Results
• Positive Sentiment: Robert W. Baird raised its price target to $31 and kept an “outperform” rating, signaling strong analyst conviction about upside potential. Benzinga
• Positive Sentiment: JPMorgan lifted its target from $26 to $29 (maintaining a “neutral” rating), which still represents meaningful upside from recent levels and supports the case for further re-rating if execution continues. Benzinga
• Positive Sentiment: Analyst and media write-ups highlight broad-based outperformance and new growth drivers after the quarter — useful context if management can sustain margin expansion and revenue momentum. Seeking Alpha
• Neutral Sentiment: Full earnings materials (call transcript and slide deck) are available for investors to review management commentary and margin drivers. Key details from the call will determine whether the beat is sustainable. Earnings Call Transcript
• Neutral Sentiment: Analyst notes and metric breakdowns (Zacks, MarketBeat coverage) provide detail on ROE, net margin and operating leverage — helpful for modeling but not decisive alone. Zacks
• Negative Sentiment: FY‑2026 guidance (EPS 1.350–1.450) was mixed vs. Street expectations — the range overlaps consensus but the lower bound and guidance cadence may have disappointed some investors, contributing to the sell-off. MarketBeat: Earnings & Guidance
• Negative Sentiment: Trading action: the stock is down on much higher-than-average volume (around 12M vs. ~2.3M average), indicating a broad, conviction-driven sell reaction rather than light, short‑term profit-taking. MarketBeat: NVST Quote

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.